EP3757126
AÐFERÐIR TIL AÐ MEÐHÖNDLA SÓRALIÐBÓLGU MEÐ IL-17 BLOKKA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.11.2011EP published:
3.9.2025EP application number:
20187001.1
EP translation filed:
29.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
3.11.2031Expiry date:
3.11.2026Next due date:
30.11.2026
Title in English:
METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTSLanguage of the patent:
English
Timeline
Today
4.11.2011EP application
3.9.2025EP Publication
29.9.2025Translation submitted
15.10.2025Registration published
3.11.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
MPOFU, ShepardAddress:
4002 Basel, CH
Name:
RICHARDS, HannoAddress:
4002 Basel, CH
Name:
THANGAVELU, KarthinathanAddress:
4002 Basel, CH
Name:
MACHACEK, MatthiasAddress:
4002 Basel, CH
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
41053310 PDate:
5.11.2010Country:
US
Classification
Categories:
C07K 16/24, A61K 39/395, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 19.11.2025
Expires: 3.11.2026
Payer: Árnason Faktor ehf.